258 related articles for article (PubMed ID: 24847054)
1. The P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP.
Xie R; Xu J; Wen G; Jin H; Liu X; Yang Y; Ji B; Jiang Y; Song P; Dong H; Tuo B
J Biol Chem; 2014 Jul; 289(27):19137-49. PubMed ID: 24847054
[TBL] [Abstract][Full Text] [Related]
2. Extracellular ATP and Purinergic P2Y
Schulien I; Hockenjos B; van Marck V; Ayata CK; Follo M; Thimme R; Hasselblatt P
Cancer Res; 2020 Feb; 80(4):699-708. PubMed ID: 31822494
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of P2Y2 nucleotide receptor in human hepatocellular carcinoma cells.
Tak E; Jun DY; Kim SH; Park GC; Lee J; Hwang S; Song GW; Lee SG
J Int Med Res; 2016 Dec; 44(6):1234-1247. PubMed ID: 27807254
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma-specific expression of P2Y11 receptor and its contribution in ATP-induced purinergic signalling and cell migration in human hepatocellular carcinoma cells.
Khalid M; Brisson L; Tariq M; Hao Y; Guibon R; Fromont G; Mortadza SAS; Mousawi F; Manzoor S; Roger S; Jiang LH
Oncotarget; 2017 Jun; 8(23):37278-37290. PubMed ID: 28418839
[TBL] [Abstract][Full Text] [Related]
5. P2Y
Zaparte A; Cappellari AR; Brandão CA; de Souza JB; Borges TJ; Kist LW; Bogo MR; Zerbini LF; Ribeiro Pinto LF; Glaser T; Gonçalves MCB; Naaldijk Y; Ulrich H; Morrone FB
Eur J Pharmacol; 2021 Jan; 891():173687. PubMed ID: 33130276
[TBL] [Abstract][Full Text] [Related]
6. P2Y
Khalafalla FG; Greene S; Khan H; Ilves K; Monsanto MM; Alvarez R; Chavarria M; Nguyen J; Norman B; Dembitsky WP; Sussman MA
Circ Res; 2017 Nov; 121(11):1224-1236. PubMed ID: 28923792
[TBL] [Abstract][Full Text] [Related]
7. P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells.
Jin H; Eun SY; Lee JS; Park SW; Lee JH; Chang KC; Kim HJ
Breast Cancer Res; 2014 Aug; 16(5):R77. PubMed ID: 25156554
[TBL] [Abstract][Full Text] [Related]
8. Ca(2+) spiking activity caused by the activation of store-operated Ca(2+) channels mediates TNF-α release from microglial cells under chronic purinergic stimulation.
Ikeda M; Tsuno S; Sugiyama T; Hashimoto A; Yamoto K; Takeuchi K; Kishi H; Mizuguchi H; Kohsaka SI; Yoshioka T
Biochim Biophys Acta; 2013 Dec; 1833(12):2573-2585. PubMed ID: 23830920
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal exocytosis of ATP is coupled to P2Y
Liu B; Cao W; Li J; Liu J
Cell Calcium; 2018 Dec; 76():62-71. PubMed ID: 30273839
[TBL] [Abstract][Full Text] [Related]
10. P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients.
Maynard JP; Lee JS; Sohn BH; Yu X; Lopez-Terrada D; Finegold MJ; Goss JA; Thevananther S
Oncotarget; 2015 Dec; 6(38):41162-79. PubMed ID: 26517690
[TBL] [Abstract][Full Text] [Related]
11. Caveolin-1 Regulates the P2Y2 Receptor Signaling in Human 1321N1 Astrocytoma Cells.
Martinez NA; Ayala AM; Martinez M; Martinez-Rivera FJ; Miranda JD; Silva WI
J Biol Chem; 2016 Jun; 291(23):12208-22. PubMed ID: 27129210
[TBL] [Abstract][Full Text] [Related]
12. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
14. Diquafosol promotes corneal epithelial healing via intracellular calcium-mediated ERK activation.
Byun YS; Yoo YS; Kwon JY; Joo JS; Lim SA; Whang WJ; Mok JW; Choi JS; Joo CK
Exp Eye Res; 2016 Feb; 143():89-97. PubMed ID: 26505315
[TBL] [Abstract][Full Text] [Related]
15. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
16. Blockade of store-operated Ca(2+) entry inhibits hepatocarcinoma cell migration and invasion by regulating focal adhesion turnover.
Yang N; Tang Y; Wang F; Zhang H; Xu D; Shen Y; Sun S; Yang G
Cancer Lett; 2013 Apr; 330(2):163-9. PubMed ID: 23211538
[TBL] [Abstract][Full Text] [Related]
17. P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer.
Jin H; Ko YS; Kim HJ
Int J Oncol; 2018 Nov; 53(5):1953-1966. PubMed ID: 30226596
[TBL] [Abstract][Full Text] [Related]
18. P2Y
Sophocleous RA; Miles NA; Ooi L; Sluyter R
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202978
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
20. Purinergic P2Y2 receptors mediate rapid Ca(2+) mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells.
Raqeeb A; Sheng J; Ao N; Braun AP
Cell Calcium; 2011 Apr; 49(4):240-8. PubMed ID: 21414662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
